1. |
Meybohm P, Zacharowski K, Cremer J, et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial--the RIPHeart-Study. Eur Heart J, 2012, 33(12):1423-1426.
|
2. |
Edmunds LH. Cardiopulmonary bypass after 50 years. N Engl J Med, 2004, 351(16):1603-1606.
|
3. |
Durdu S, Sirlak M, Cetintas D, et al. The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting. J Cardiothorac Surg, 2012, 7:73.
|
4. |
Mangano DT, Tudor IC, Dietzel C. Multicenter study of periopera-tive ischemia research group; ischemia research and education foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med, 2006, 354(4):353-365.
|
5. |
Kloner RA, Jennings RB. Consequences of brief ischemia:stunning, preconditioning, and their clinical implications:part 1. Circulation, 2001, 104(24):2981-2989.
|
6. |
Schurr UP, Zünd G, Hoerstrup SP, et al. Preoperative administration of steroids:influence on adhesion molecules and cytokines after cardiopulmonary bypass. Ann Thorac Surg, 2001, 72(4):1316-320.
|
7. |
Morita K. Surgical reoxygenation injury of the myocardium in cyanotic patients:clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass. Gen Thorac Cardiovasc Surg, 2012, 60(9):549-556.
|
8. |
Wu QP, Purusram G, Wang HQ, et al. The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery. Br J Clin Pharmacol, 2013, 75(3):769-778.
|
9. |
Rezkalla SH, Kloner RA. No-Reflow Phenomenon. Circulation, 2002, 105(5):656-662.
|
10. |
Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest, 2001, 107(11):1395-1402.
|
11. |
Eltzschig HK, Carmeliet P. Hypoxia and Inflammation. N Engl J Med, 2011, 364(7):656-665.
|
12. |
Karhausen J, Haase VH, Colgan SP. Inflammatory hypoxia:role of hypoxia-inducible factor. Cell Cycle, 2005, 4(2):256-258.
|
13. |
Colgan SP, Eltzschig HK. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol, 2012, 74:153-175.
|
14. |
Verma S, Fedak PW, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation, 2002, 105(20):2332-2336.
|
15. |
Gupta-Malhotra M, Kern JH, Flynn PA, et al. Cardiac troponin Ⅰ after cardiopulmonary bypass in infants in comparison with older children. Cardiol Young, 2013, 23(3):431-435.
|
16. |
Perrelli MG, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms:Role of mitochondria and reactive oxygen species. World J Cardiol, 2011, 3(6):186-200.
|
17. |
Whitehouse JS, Riggle KM, Purpi DP, et al. The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis. J Surg Res, 2010, 163(1):79-85.
|
18. |
Boodram S, Evans E. Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass:a review. J Extra Corpor Technol, 2008, 40(1):27-42.
|
19. |
Bhakri K, Mulholland J, Punjabi P. Understanding innovations in the evolving practice of blood and crystalloid cardioplegia. Perfusion, 2014, [Epub ahead of print].
|
20. |
Abah U, Garfjeld Roberts P, Ishaq M, et al. Is cold or warm blood cardioplegia superior for myocardial protection? Interact Cardiovasc Thorac Surg, 2012, 14(6):848-855.
|
21. |
Mauney MC, Kron IL. The physiologic basis of warm cardioplegia. Ann Thorac Surg, 1995, 60(3):819-823.
|
22. |
Albert AA, Arnrich B, Walter JA, et al. Hyperkalemic blood versus crystalloid cardioplegia in longer clamping times. Asian Cardiovasc Thorac Ann, 2004, 12(2):115-120.
|
23. |
Franke UF, Korsch S, Wittwer T, et al. Intermittent antegrade warm myocardial protection compared to intermittent cold blood cardioplegia in elective coronary surgery--do we have to change? Eur J Cardiothorac Surg, 2003, 23(3):341-346.
|
24. |
Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury:preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol, 2011, 301(5):H1723-H1741.
|
25. |
Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery:a randomised controlled trial. Lancet, 2007, 370(9587):575-579.
|
26. |
Ascione R, Suleiman SM, Angelini GD. Retrograde hot-shot cardioplegia in patients with left ventricular hypertrophy undergoing aortic valve replacement. Ann Thorac Surg, 2008, 85(2):454-458.
|
27. |
Kouerinis IA, Manopoulos CG, Zografos GC, et al. Retrograde cardioplegia in CABG:is it really useful? The microcirculation and a capillary unit model. Med Sci Monit, 2006, 12(11):265-268.
|
28. |
Fazel S, Borger MA, Weisel RD, et al. Myocardial protection in reoperative coronary artery bypass grafting:J Card Surg, 2004, 19(4):291-295.
|
29. |
Nader ND, Karamanoukian HL, Reedy RL, et al. Inclusion of sevof-lurane in cardioplegia reduces neutrophil activity during cardiopulmonary bypass. J Cardiothorac Vasc Anesth, 2006, 20(1):57-62.
|
30. |
Chouraqui P, Rabinowitz B, Livschitz S, et al. Effects of antegrade versus combined antegrade/retrograde cardioplegia on postoperative septal wall motion in patients undergoing open heart surgery. Cardiology, 1998, 88(6):526-529.
|
31. |
Walsh SR, Tang TY, Kullar P, et al. Ischaemic preconditioning during cardiac surgery:systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg, 2008, 34(5):985.
|
32. |
Kolwicz SC, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res, 2013, 113(5):603-616.
|
33. |
Maslov LN, Lishmanovlu B, Headrick JP, et al. Perspective of crea-tion of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion. Eksp Klin Farmakol, 2012, 75(10):22-28.
|
34. |
Landoni G, Turi S, Bignami E, et al. Organ protection by volatile anesthetics in non-coronary artery bypass grafting surgery. Future Cardiol, 2009, 5(6):589-603.
|
35. |
Zaugg M, Lucchinetti E. Sevoflurane-compared with propofol-based anesthesia reduces the need for inotropic support in patients undergoing abdominal aortic aneurysm repair:evidence of cardioprotection by volatile anesthetics in noncardiac surgery. Anesthesiology, 2014, 120(5):1289-1290.
|
36. |
Venugopal V, Hausenloy DJ, Ludman A, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia:a randomised controlled trial. Heart, 2009, 95(19):1567-1571.
|
37. |
Esmon CT. The interactions between inflammation and coagulation. Br J Haematol, 2005, 131(4):417-430.
|
38. |
Kawamura T, Nara N, Kadosaki M, et al. Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Crit Care Med, 2000, 28(7):2201-2208.
|
39. |
Kanemitsu S, Nishikawa M, Onoda K, et al. Pharmacologic platelet anesthesia by glycoprotein Ⅱb/Ⅲa complex antagonist and argatroban during in vitro extracorporeal circulation. J Thorac Cardiovasc Surg, 2003, 126(2):428-435.
|
40. |
Chung A, Wildhirt SM, Wang S, et al. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction:a pilot clinical study. J Thorac Cardiovasc Surg, 2005, 129(4):782-790.
|
41. |
Troncy E, Hubert B, Pang D, et al. Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extr-acorporeal circulation in a pig model. Nitric Oxide, 2006, 14(3):261-271.
|
42. |
Andreadou I, Iliodromitis EK, Rassaf T, et al. The role of gasotransmitters NO, H2 S, CO in myocardial ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Br J Pharmacol, 2014, doi:10.1111/bph.12811.[Epubaheadofprint].
|
43. |
Hubble CL, Cheifetz IM, Craig DM, et al. Inhaled nitric oxide results in deteriorating hemodynamics when administered during cardiopulmonary bypass in neonatal swine. Pediatr Crit Care Med, 2004, 5(2):157-162.
|
44. |
Asanuma H, Sanada S, Asakura M, et al. Carperitide induces coronary vasodilation and limits infarct size in canine ischemic hearts:role of NO. Hypertens Res, 2014, doi:10.1038/hr.2014.70.[Epubaheadofprint].
|
45. |
Carrier M, Perrault LP, Fortier A, et al. L-arginine supplemented nondiluted blood cardioplegia:a clinical trial. J Cardiovasc Surg (Torino), 2010, 51(2):283-287.
|